- Pluristem's (PSTI +5%) PLX-PAD placenta-derived stem-cell therapy for muscle injuries appeared to be safe and effective in treating orthopedic injuries in a Phase I/II trial
- "Patients treated with PLX-PAD had a greater improved change of maximal voluntary muscle contraction force than the placebo group," Pluristem says. The injured muscle studied was the gluteus medius in the buttock.
- The trial participants who received the treatment showed a 300% improvement vs a placebo.
Pluristem muscle treatment meets endpoints in trial
Jan 21 2014, 09:01 ET